Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Somnox is a Dutch health technology company that develops soft-robotic devices designed to improve sleep quality through natural physiological regulation. The company's flagship product, the Somnox Sleep Robot, is a tactile breathing aid that users hug during sleep; it uses rhythmic expansion and contraction to guide the user's breathing into a slower, more relaxed state. By leveraging the principle of respiratory entrainment, the device helps reduce stress and anxiety, allowing users to fall asleep faster and stay asleep longer without the use of pharmaceuticals. Founded as a spin-off from the Delft University of Technology, Somnox combines robotics, sleep science, and human-centric design to address the global epidemic of sleep deprivation. The company currently markets its second-generation device, Somnox 2, to consumers and healthcare partners worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Somnox.